Literature DB >> 34125141

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.

Eleni Linos1, Mary-Margaret Chren2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34125141      PMCID： PMC9075932          DOI： 10.1001/jamainternmed.2021.2643

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   44.409


× No keyword cloud information.
  9 in total

1.  Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.

Authors:  Brandon A Mahal; Santino Butler; Idalid Franco; Daniel E Spratt; Timothy R Rebbeck; Anthony V D'Amico; Paul L Nguyen
Journal:  JAMA       Date:  2019-02-19       Impact factor: 56.272

2.  Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy.

Authors:  Eleni Linos; Steven A Schroeder; Mary-Margaret Chren
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

3.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Authors:  Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron
Journal:  Arch Dermatol       Date:  2010-03

4.  Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer.

Authors:  Kerri E Rieger; Eleni Linos; Barbara M Egbert; Susan M Swetter
Journal:  J Cutan Pathol       Date:  2009-07-13       Impact factor: 1.587

5.  Patient-reported problems after office procedures.

Authors:  Eleni Linos; Mackenzie R Wehner; Dominick L Frosch; Louise Walter; Mary Margaret Chren
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

6.  Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.

Authors:  Eleni Linos; Rupa Parvataneni; Sarah E Stuart; W John Boscardin; C Seth Landefeld; Mary-Margaret Chren
Journal:  JAMA Intern Med       Date:  2013-06-10       Impact factor: 21.873

7.  Active surveillance of low-risk papillary thyroid cancer: A meta-analysis.

Authors:  Bianka Saravana-Bawan; Amandeep Bajwa; John Paterson; Todd McMullen
Journal:  Surgery       Date:  2019-09-13       Impact factor: 3.982

8.  Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.

Authors:  M R Wehner; N Dalma; C Landefeld; A Pare-Anastasiadou; I Koutelidas; M M Chren; N Aji; C E Teng; B A Koenig; J Tang; K Covinsky; E Linos
Journal:  Br J Dermatol       Date:  2018-07-12       Impact factor: 9.302

9.  The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).

Authors:  E Shelley Hwang; Terry Hyslop; Thomas Lynch; Elizabeth Frank; Donna Pinto; Desiree Basila; Deborah Collyar; Antonia Bennett; Celia Kaplan; Shoshana Rosenberg; Alastair Thompson; Anna Weiss; Ann Partridge
Journal:  BMJ Open       Date:  2019-03-12       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.